Adrenergic microenvironment driven by cancer‐associated Schwann cells contributes to chemoresistance in patients with lung cancer

Yusuke Otani,Haruyoshi Katayama,Yidan Zhu,Rongsheng Huang,Takafumi Shigehira,Kazuhiko Shien,Ken Suzawa,Hiromasa Yamamoto,Tadahiko Shien,Shinichi Toyooka,Atsushi Fujimura
DOI: https://doi.org/10.1111/cas.16164
IF: 5.7
2024-04-28
Cancer Science
Abstract:Schwann cells exist in the peri‐bronchiole and visceral pleura in the normal lung. Upon stimulation from cancer cells, Schwann cells acquire DCX positivity and sympathetic neuron‐like properties via the activation of YAP/TAZ signaling. Cancer‐associated Schwann cells (CAS) express catecholamine‐synthesizing enzymes and synthesize adrenaline, which may promote the cancer stemness of lung cancer cells close to CAS. Doublecortin (DCX)‐positive neural progenitor‐like cells are purported components of the cancer microenvironment. The number of DCX‐positive cells in tissues reportedly correlates with cancer progression; however, little is known about the mechanism by which these cells affect cancer progression. Here we demonstrated that DCX‐positive cells, which are found in all major histological subtypes of lung cancer, are cancer‐associated Schwann cells (CAS) and contribute to the chemoresistance of lung cancer cells by establishing an adrenergic microenvironment. Mechanistically, the activation of the Hippo transducer YAP/TAZ was involved in the acquisition of new traits of CAS and DCX positivity. We further revealed that CAS express catecholamine‐synthesizing enzymes and synthesize adrenaline, which potentiates the chemoresistance of lung cancer cells through the activation of YAP/TAZ. Our findings shed light on CAS, which drive the formation of an adrenergic microenvironment by the reciprocal regulation of YAP/TAZ in lung cancer tissues.
oncology
What problem does this paper attempt to address?